CSIMarket
 


Verastem inc   (VSTM)
Other Ticker:  
 
 

VSTM's Free Cash Flow Growth by Quarter and Year

Verastem Inc 's Free Cash Flow results by quarter and year




VSTM Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -29.68 -16.62 -9.93 -21.70
III Quarter September -16.59 -15.08 -10.83 44.75
II Quarter June -19.90 -12.69 -13.42 -22.55
I Quarter March -20.29 -19.28 -19.32 -34.00
FY   -86.46 -63.67 -53.50 -33.50



VSTM Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Verastem inc in the fourth quarter 2023 recorded free cash outflow of $ -29.68 millions.

According to the results reported in the fourth quarter 2023, Verastem Inc achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Verastem Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




VSTM Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Verastem Inc 's fourth quarter 2023 Free Cash Flow $ -29.68 millions VSTM's Income Statement
Verastem Inc 's fourth quarter 2022 Free Cash Flow $ -16.62 millions Quarterly VSTM's Income Statement
New: More VSTM's historic Free Cash Flow Growth >>


VSTM Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Verastem Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VSTM's IV. Quarter Q/Q Free Cash Flow Comment
Current results of -29.68 millions by Verastem inc look even less good considering the -16.59 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Verastem inc achieved highest sequential Free Cash Flow growth. While Verastem Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VSTM's IV. Quarter Q/Q Free Cash Flow Comment
Current free cash outflow of -29.68 millions by Verastem inc come out even less good considering the -16.59 millions free cash outflow in the third quarter.

Within Major Pharmaceutical Preparations industry Verastem inc achieved highest sequential Free Cash Flow growth. While Verastem Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Verastem Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ -86.46 $ -73.40 $ -71.89 $ -64.68 $ -63.67
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Verastem Inc ' has realized cumulative trailing twelve months free cash outflow of $ -86 millions in the Dec 31 2023 period.
The situation is detiriorating as the cumulative free cash outflow is inflating from $ -73.4 millions for the period from Sep 30 2023 to Dec 31 2022 and $ -56.99 millions for the twelve months ending in the quarter Dec 31 2022 Javier Díaz mentioned.

Verastem inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Verastem Inc ' has realized cumulative trailing twelve months free cash outflow of $ -86 millions in the Dec 31 2023 period.
The situation is getting worse as the cumulative free cash outflow is becoming larger from $ -73.4 millions in TTM ending quarter Sep 30 2023 and $ -56.99 millions for the twelve months ending in the quarter Dec 31 2022 Javier Díaz wrote.

Verastem inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
VSTM's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for VSTM's Competitors
Free Cash Flow Growth for Verastem Inc 's Suppliers
Free Cash Flow Growth for VSTM's Customers

You may also want to know
VSTM's Annual Growth Rates VSTM's Profitability Ratios VSTM's Asset Turnover Ratio VSTM's Dividend Growth
VSTM's Roe VSTM's Valuation Ratios VSTM's Financial Strength Ratios VSTM's Dividend Payout Ratio
VSTM's Roa VSTM's Inventory Turnover Ratio VSTM's Growth Rates VSTM's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Merit Medical Systems Inc122.26%$ 122.261 millions
Privia Health Group Inc 119.87%$ 119.870 millions
Healthcare Services Group Inc 115.98%$ 115.983 millions
National Healthcare Corp115.63%$ 115.628 millions
Becton Dickinson And Company114.29%$ 114.286 millions
Resmed Inc 112.10%$ 112.096 millions
Icon Plc106.11%$ 106.106 millions
Teladoc Health Inc 98.45%$ 98.450 millions
Bioventus Inc 97.83%$ 97.826 millions
Tenet Healthcare Corp95.72%$ 95.724 millions
Utah Medical Products Inc84.03%$ 84.032 millions
Lifevantage Corp81.70%$ 81.696 millions
Alpha Pro Tech Ltd 81.35%$ 81.346 millions
Viemed Healthcare Inc 72.88%$ 72.879 millions
Ensign Group Inc69.94%$ 69.940 millions
Globus Medical Inc 63.62%$ 63.617 millions
Harvard Bioscience Inc60.62%$ 60.620 millions
Adapthealth Corp 60.20%$ 60.200 millions
Veracyte inc 59.61%$ 59.606 millions
Cadre Holdings Inc 59.39%$ 59.386 millions
Quest Diagnostics Inc57.78%$ 57.784 millions
Cytek Biosciences Inc 53.59%$ 53.593 millions
Stryker Corp52.34%$ 52.343 millions
Organon and Co 48.69%$ 48.689 millions
Amedisys Inc 47.52%$ 47.521 millions
Vericel Corporation44.60%$ 44.602 millions
National Research Corporation44.47%$ 44.472 millions
Idexx Laboratories Inc44.07%$ 44.066 millions
Steris Plc41.67%$ 41.670 millions
Teleflex Incorporated41.60%$ 41.600 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com